Biotransformation of anabolic androgenic steroids in human skin cells.

Détails

ID Serval
serval:BIB_D3DDF8768831
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Biotransformation of anabolic androgenic steroids in human skin cells.
Périodique
The Journal of steroid biochemistry and molecular biology
Auteur⸱e⸱s
Liu L., Karim Z., Schlörer N., Torre X., Botrè F., Zoschke C., Parr M.K.
ISSN
1879-1220 (Electronic)
ISSN-L
0960-0760
Statut éditorial
Publié
Date de publication
03/2024
Peer-reviewed
Oui
Volume
237
Pages
106444
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
In comparison to well-known drug-metabolizing organs such as the liver, the metabolic capacity of human skin is still not well elucidated despite the widespread use of topical drug application. To gain a comprehensive insight into anabolic steroid metabolism in the skin, six structurally related anabolic androgenic steroids, testosterone, metandienone, methyltestosterone, clostebol, dehydrochloromethyltestosterone, and methylclostebol, were applied to human keratinocytes and fibroblasts derived from the juvenile foreskin. Phase I metabolites obtained from incubation media were analyzed by gas chromatography-mass spectrometry. The 5α-reductase activity was predominant in the metabolic pathways as supported by the detection of 5α-reduced metabolites after incubation of testosterone, methyltestosterone, clostebol, and methylclostebol. Additionally, the stereochemistry structures of fully reduced metabolites (4α,5α-isomers) of clostebol and methylclostebol were newly confirmed in this study by the help of inhouse synthesized reference materials. The results provide insights into the steroid metabolism in human skin cells with respect to the characteristics of the chemical structures.
Mots-clé
anabolic androgenic steroids, doping control, fibroblasts, gas chromatography mass spectrometry, keratinocytes, phase I metabolism
Pubmed
Création de la notice
19/12/2023 9:16
Dernière modification de la notice
13/02/2024 8:23
Données d'usage